5 Most Profitable Pot Stocks Now

4. InterCure Ltd. (NASDAQ:INCR)

Trailing Twelve Month Net Income: $9 million

InterCure Ltd. (NASDAQ:INCR) is another Israeli company. The firm engages in the production and sales of medical cannabis all over the world. For the first half of 2023, its revenue stood at $75 million, marking 14% annual growth and a new record.

During Q3 2023, just two out of the 910 hedge funds part of Insider Monkey’s database had bought a stake in InterCure Ltd. (NASDAQ:INCR). The firm’s biggest hedge fund shareholder is Ken Griffin’s Citadel Investment Group as it owns 52,541 shares that are worth $83,015.

Follow Intercure Ltd.